Arbutus Biopharma Corporation (ABUS)

[Purple Wonder]

Almost time for the next leg up. Strong HBV results continue to be announced. Patented technology being used by 1 or more Covid-19 vaccines being rolled out. What more could an investor ask for when putting money into a young biotech company? Minimal downside, huge upside. The MC of ABUS should be 1B mininum and that would put us a double from here. Still holding and adding on dips. Hoping for a major market adjustment soon to reflect ABUS true valuation.